CLOV Stock Summary and Trading Ideas (Clover Health Investments Corp. - Class A | NASDAQ:CLOV)

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Clover Health Investments Corp. - Class A trades on the NASDAQ stock market under the symbol CLOV.

As of August 24, 2026, CLOV stock price declined to $4.11 with 2,527,151 million shares trading.

CLOV has a beta of 2.59, meaning it tends to be more sensitive to market movements. CLOV has a correlation of 0.18 to the broad based SPY ETF.

CLOV has a market cap of $2.18 billion. This is considered a Mid Cap stock.

Last quarter Clover Health Investments Corp. - Class A reported $743 million in Revenue and $.05 earnings per share. This beat revenue expectation by $15 million and exceeded earnings estimates by $.01.

In the last 3 years, CLOV traded as high as $5.59 and as low as $.61.

The top ETF exchange traded funds that CLOV belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

CLOV has outperformed the market in the last year with a return of +57.5%, while the SPY ETF gained +21.3%. In the last 3 month period, CLOV beat the market returning +14.2%, while SPY returned +3.1%. However, in the most recent 2 weeks CLOV has underperformed the stock market by returning -13.7%, while SPY returned -1.3%.

CLOV support price is $4.02 and resistance is $4.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLOV shares will trade within this expected range on the day.